Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism

European Journal of Pharmacology

Volumn 744, Issue , 2015, Pages 52-58

  Wang, Chaoyun ^a   Shi, Chunfeng ^a   Yang, Xiaoping ^a   Yang, Ming ^a   Sun, Hongliu ^a   Wang, Chunhua ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CELASTROL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIMVASTATIN; TRIACYLGLYCEROL; ANTIOXIDANT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRIPTERINE; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; EMULSION; ENZYME ACTIVITY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; BLOOD; DRUG EFFECTS; LIPID DIET; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATP BINDING CASSETTE TRANSPORTER 1; DIET, HIGH-FAT; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; NADP; OBESITY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES; TRITERPENES;

EID: 84918814582     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.09.043     Document Type: Article

References (34)

1. F.C. Barone, W.G. Campbell Jr., A.H. Nelson, and G.Z. Feuerstein Carvedilol prevents severe hypertensive cardiomyopathy and remodeling J. Hypertens. 16 1998 871 884
2. M. Bodzioch, E. Orsó, J. Klucken, T. Langmann, A. Böttcher, W. Diederich, W. Drobnik, S. Barlage, C. Büchler, M. Porsch-Ozcürümez, W.E. Kaminski, H.W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K.J. Lackner, and G. Schmitz The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease Nat. Genet. 22 1999 347 351
3. H.B. Brewer Jr. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease Arterioscler. Thromb. Vasc. Biol. 24 2004 387 391
4. L.R. Brunham, J.K. Kruit, J. Iqbal, C. Fievet, J.M. Timmins, T.D. Pape, B.A. Coburn, N. Bissada, B. Staels, A.K. Groen, M.M. Hussain, J.S. Parks, F. Kuipers, and M.R. Hayden Intestinal ABCA1 directly contributes to HDL biogenesis in vivo J. Clin. Invest. 116 2006 1052 1062
5. M. Carmiel-Haggai, A.I. Cederbaum, and N. Nieto A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats FASEB J. 19 2005 136 138
6. B.A. Christopher, H.M. Huang, J.M. Berthiaume, T.A. McElfresh, X. Chen, C.M. Croniger, R.F. Muzic Jr., and M.P. Chandler Myocardial insulin resistance induced by high fat feeding in heart failure is associated with preserved contractile function Am. J. Physiol. Heart Circ. Physiol. 299 2010 H1917 H1927
7. H.M. Colhoun, D.J. Betteridge, P.N. Durrington, G.A. Hitman, H.A. Neil, S.J. Livingstone, M.J. Thomason, M.I. Mackness, V. Charlton-Menys, and J.H. Fuller Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomized placebo-controlled trial Lancet 364 2004 685 696
8. F. Conforti, S. Sosa, M. Marrelli, F. Menichini, G.A. Statti, D. Uzunov, A. Tubaro, and F. Menichini The protective ability of Mediterranean dietary plants against the oxidative damage: the role of radical oxygen species in inflammation and the polyphenol, flavonoid and sterol contents Food Chem. 112 2009 587 594
9. S. Delbosc, E. Paizanis, R. Magous, C. Araiz, T. Dimo, J.P. Cristol, G. Cros, and J. Azay Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat Atherosclerosis 179 2005 43 49
10. S. De Minicis, C. Rychlicki, L. Agostinelli, S. Saccomanno, C. Candelaresi, L. Trozzi, E. Mingarelli, B. Facinelli, G. Magi, C. Palmieri, M. Marzioni, A. Benedetti, and G. Svegliati-Baroni Dysbiosis contributes to fibrogenesis in the course of chronic liver injury Hepatology 59 2014 1738 1749
11. S.P. Didion, M.J. Ryan, L.A. Didion, P.E. Fegen, C.D. Sigmund, and F.M. Faraci Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice Circ. Res. 91 2002 938 944
12. M.L. Fitzgerald, Z. Mujawar, and N. Tamehiro ABC transporters, atherosclerosis and inflammation Atherosclerosis 211 2010 361 370
13. K.K. Griendling, D. Sorescu, and M. Ushio-Fukai NAD(P)H oxidase: role in cardiovascular biology and disease Circ. Res. 86 2000 494 501
14. Y.S. Kang Obesity associated hypertension: new insights into mechanism Electrolyte Blood Press 11 2013 46 52
15. D.Y. Kim, J.W. Park, D. Jeoung, and J.Y. Ro Celastrol suppresses allergeninduced airway inflammation in a mouse allergic asthma model Eur. J. Pharmacol. 612 2009 98 105
16. B. Lassègue, and R.E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 2003 R277 R297
17. G.F. Lewis Determinants of plasma HDL concentrations and reverse cholesterol transport Curr. Opin. Cardiol. 21 2006 345 352
18. LIPID Study Group (Long-term intervention with pravastatin in ischaemic disease) Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up Lancet 359 2002 1379 1387
19. J. McNeish, R.J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K.L. Hoppe, M.L. Roach, L.J. Royer, J. De Wet, C. Broccardo, G. Chimini, and O.L. Francone High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1 Proc. Natl. Acad. Sci. USA 97 2000 4245 4250
20. D. Meetoo Chronic diseases: the silent global epidemic Br. J. Nurs. 17 2008 1320 1325
21. B. Nolan, M. Hess, A. Howell, J.V. Martin, G.C. Wagner, and H. Fisher High vitamin E and selenium elevate, whereas diphenyl-para-phenylenediamine plus caffeine lowers liver fat in alcohol-fed rats Nutr. Res. 25 2005 701 709
22. E. Orsó, C. Broccardo, W.E. Kaminski, A. Böttcher, G. Liebisch, W. Drobnik, A. Götz, O. Chambenoit, W. Diederich, T. Langmann, T. Spruss, M.F. Luciani, G. Rothe, K.J. Lackner, G. Chimini, and G. Schmitz Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice Nat. Genet. 24 2000 192 196
23. D. Qiu, and P.N. Kao Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs RD 4 2003 1 18
24. C.K. Roberts, R.J. Barnard, R.K. Sindhu, M. Jurczak, A. Ehdaie, and N.D. Vaziri Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes indiet-induced metabolic syndrome Metabolism 55 2006 928 934
25. R.R. Singaraja, M. Van Eck, N. Bissada, F. Zimetti, H.L. Collins, R.B. Hildebrand, A. Hayden, L.R. Brunham, M.H. Kang, J.C. Fruchart, T.J. Van Berkel, J.S. Parks, B. Staels, G.H. Rothblat, C. Fiévet, and M.R. Hayden Both hepatic and extrahepatic ABCA1have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo Circulation 114 2006 1301 1309
26. B. Staels, and V.A. Fonseca Bile acids and metabolic regulation:mechanisms and clinical responses to bile acid sequestration Diabetes Care 32 2009 S237 S245
27. D. Steinberg The pathogenesis of atherosclerosis an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia in the pathogenesis J. Lipid Res. 46 2005 2037 2051
28. X. Tao, J. Younger, F.Z. Fan, B. Wang, and P.E. Lipsky Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a doubleblind, placebo-controlled study Arthritis Rheumatol. 46 2002 1735 1743
29. M. Tölle, A. Pawlak, M. Schuchardt, A. Kawamura, U.J. Tietge, S. Lorkowski, P. Keul, G. Assmann, J. Chun, B. Levkau, M. van der Giet, and J.R. Nofer HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production Arterioscler. Thromb. Vasc. Biol. 28 2008 1542 1548
30. phox expression Toxicol. Appl. Pharmacol. 273 2013 59 67
31. K.J. Williams, and I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler. Thromb. Vasc. Biol. 15 1995 551 561
32. C. Xu, Z. Haiyan, Z. Hua, Z. Jianhong, and D. Pin Effect of Curcuma kwangsiensis polysaccharides on blood lipid profiles and oxidative stress in high-fat rats Int. J. Biol. Macromol. 44 2009 138 142
33. M. Yan, J.L. Mehta, and C. Hu LOX-1 and obesity Cardiovasc. Drugs Ther. 25 2011 469 476
34. S. Yokoyama Assembly of high-density lipoprotein Arterioscler. Thromb. Vasc. Biol. 26 2006 20 27